ciprofloxacin has been researched along with mocetinostat in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bolgos, G; Green, L; Newcomb, D; Remick, DG | 1 |
| Falk, W; Gross, V; Hans, W; Schölmerich, J | 1 |
| Celikel, C; Cetinel, S; Dulger, GA; Imeryuz, N; Kabasakal, L; Kan, B; Orun, O; Toklu, HZ; Yuksel, M | 1 |
| Cao, J; Hill, J; Ng, FM; Peng, J | 1 |
| Mansour, HA; Masoud, MA; Sheded, MS; Yahia, R | 1 |
| Dogan, A; Donmez, F | 1 |
6 other study(ies) available for ciprofloxacin and mocetinostat
| Article | Year |
|---|---|
Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity.
Topics: Animals; Anti-Bacterial Agents; Body Temperature; Cecum; Ciprofloxacin; Clindamycin; Cytokines; Drug Therapy, Combination; Gentamicins; Imipenem; Interleukin-1; Interleukin-6; Lung; Mice; Mice, Inbred BALB C; Morbidity; Neutrophils; Peroxidase; Sepsis; Survival Rate; Tumor Necrosis Factor-alpha | 1998 |
The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Biopsy; Body Weight; Chronic Disease; Ciprofloxacin; Colon; Dextran Sulfate; Disease Models, Animal; Female; Inflammatory Bowel Diseases; Interleukins; Metronidazole; Mice; Peroxidase | 2000 |
A study comparing the efficacy of antimicrobial agents versus enzyme (P-gp) inducers in the treatment of 2,4,6 trinitrobenzenesulfonic acid-induced colitis in rats.
Topics: Animals; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Ciprofloxacin; Colitis; Colon; Glutathione; Ileum; Male; Malondialdehyde; NF-kappa B; Peroxidase; Pregnane X Receptor; Rats; Rats, Sprague-Dawley; Receptors, Steroid; Rifampin; Spironolactone; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2013 |
Pseudomonas aeruginosa develops Ciprofloxacin resistance from low to high level with distinctive proteome changes.
Topics: Anaerobiosis; Anti-Bacterial Agents; Catalase; Ciprofloxacin; DNA Repair; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Iron; Membrane Proteins; Membrane Transport Proteins; Peroxidase; Polyamines; Proteome; Pseudomonas aeruginosa; Quorum Sensing | 2017 |
The possible neurobehavioral protective effects of natural antioxidant against phototoxicity attenuation of antimicrobial quinolone group in rats.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Behavior, Animal; Cerebrum; Ciprofloxacin; Dermatitis, Phototoxic; Escherichia coli; Escherichia coli Infections; Glutathione; Locomotion; Male; Malondialdehyde; Oxidative Stress; Peroxidase; Rats; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Ultraviolet Rays | 2020 |
Investigation of the effects of three different generations of fluoroquinolone derivatives on antioxidant and immunotoxic enzyme levels in different rat tissues.
Topics: Adenosine Deaminase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Ciprofloxacin; COVID-19; Creatinine; Fluoroquinolones; Glucose; Glutathione; Glutathione Peroxidase; Levofloxacin; Lipid Peroxidation; Malondialdehyde; Moxifloxacin; Nalidixic Acid; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; SARS-CoV-2; Superoxide Dismutase; Triglycerides | 2022 |